CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 5701-5718
Publisher
Informa UK Limited
Online
2020-08-07
DOI
10.2147/ijn.s257527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer
- (2018) ANTICANCER RESEARCH
- The CXCL12/CXCR4 axis promotes migration, invasion and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling
- (2018) Yuanqiang Lin et al. Biochemistry and Cell Biology
- Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics
- (2018) Marta Overchuk et al. BIOMATERIALS
- Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway
- (2018) Zhihu Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
- (2018) Deli Hong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
- (2018) Yan Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improve long circulation and enhance cellular uptake in cancer therapy
- (2018) Lu Zhong et al. Acta Pharmaceutica Sinica B
- Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
- (2017) T L Mao et al. GENE THERAPY
- Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support
- (2017) Young Kwang Chae et al. MOLECULAR CANCER THERAPEUTICS
- Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention
- (2017) Ning Zheng et al. MOLECULAR CARCINOGENESIS
- RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer
- (2017) Fang Li et al. MOLECULAR PHARMACEUTICS
- Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
- (2017) Hyun Hee Lee et al. PLoS One
- Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs
- (2016) Fangrong Zhang et al. AAPS PHARMSCITECH
- Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma
- (2016) Yuansheng Duan et al. Oncology Letters
- Nano-assembly of bovine serum albumin driven by rare-earth-ion (Gd) biomineralization for highly efficient photodynamic therapy and tumor imaging
- (2016) Ya Wen et al. Journal of Materials Chemistry B
- Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials
- (2016) Eun Ji Hong et al. Acta Pharmaceutica Sinica B
- Does ligand–receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?
- (2015) Wei-Qiang Zhang et al. JOURNAL OF DRUG TARGETING
- CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer
- (2015) Qing Guo et al. ONCOLOGY RESEARCH
- Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer
- (2015) Namdev L. Dhas et al. POWDER TECHNOLOGY
- Noninvasive Imaging Reveals Inhibition of Ovarian Cancer by Targeting CXCL12-CXCR4
- (2015) Paramita Ray et al. NEOPLASIA
- CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
- (2014) Urszula M. Domanska et al. CLINICAL & EXPERIMENTAL METASTASIS
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Xuqi Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Polymeric Plerixafor: Effect of PEGylation on CXCR4 Antagonism, Cancer Cell Invasion, and DNA Transfection
- (2014) Yan Wang et al. PHARMACEUTICAL RESEARCH
- Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
- (2013) Paraskevi Mallini et al. CANCER TREATMENT REVIEWS
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
- (2012) Xuqi Li et al. CANCER LETTERS
- Design of a Cellular-Uptake-Shielding “Plug and Play” Template for Photo Controllable Drug Release
- (2011) Wang Xiao et al. ADVANCED MATERIALS
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now